Integrating Social Determinants of Health into Experiential Education

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN:  0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa Clinic ReferenceGuidelinesPaper Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Stigmatizing language may be part of our daily interactions with patients without even realizing it. It can appear in charts, regardless of race, gender, gender identity, ability, or socioeconomic status, but it has been found to occur more frequently for groups who are traditionally marginalized. How often do you reflect on the language you use with patients and how it might be interpreted by them, depending on their unique circumstances? And what are we doing as preceptors to help our residents and students understand the importance of language in their patient interactions? Listen in to learn more.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestKashelle Lockman, PharmD, MAClinical Associate ProfessorUniversity of IowaGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. List examples of stigmatizing language and its impact on pharmacist-patient interactions2. Describe strategies preceptors can use to foster the use of non-stigmatizing language by students and residents0.05 CEU/0.5 HrUAN: 0107-0000-24-250-H99-PInitial release date: 8/21/2024Expiration date: 8/21/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset. The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceThe recombinant shingles vaccine is associated with lower risk of dementia Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe dementia's epidemiology and the significance of preventive interventions.2. Discuss the strengths, weaknesses, and outcomes of the study.0.05 CEU/0.5 HrUAN: 0107-0000-24-246-H01-PInitial release date: 08/19/2024Expiration date: 08/19/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPrevious GameChangers on PREVENT score Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management. The GameChangerIncorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management. GuestsMark Smith, Jr., PharmD, CDCES, AFAA-CGFIPharmacistUAB MedicineIan Haywood, PharmD, BCPS, CDCESClinical PharmacistBaptist Memorial Hospital Reference MaterialsThe Role of Exercise in DiabetesPhysical Activity and Diabetes Position from the ADASupplemental Continuing Education CoursesGlucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hrGuardians of the Glucose Galaxy: The Rise of CGMs - 1hr Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrsAdditional GameChangers EpisodesContinuous Glucose Monitors Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of physical fitness on diabetes management.2. Identify strategies for educating patients on exercise and diabetes.0.05 CEU/0.5 HrUAN: 0107-0000-24-224-H01-PInitial release date: 08/05/2024Expiration date: 08/05/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.  The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss. GuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridad ReferencesTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.0.05 CEU/0.5 HrUAN: 0107-0000-24-238-H01-PInitial release date: 07/29/2024Expiration date: 07/29/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death. The GameChangerThe study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEO, SeguridadReferencesMulti-Vitamin StudyNIH Press Release Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the use of multivitamins.2. Identify implications for healthy patients considering multivitamin use.0.05 CEU/0.5 HrUAN: 0107-0000-24-226-H01-PInitial release date: 07/22/2024Expiration date: 07/22/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?  HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestSally Arif, PharmD, BCCPProfessor of Pharmacy Practice/Clinical Cardiology PharmacistMidwestern University College of PharmacyRush Medical CenterChicago, ILGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching0.05 CEU/0.5 HrUAN: 0107-0000-24-210-H99-PInitial release date: 7/17/2024Expiration date: 7/17/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions. The GameChangerHealth outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics. GuestAnna Garrett, PharmD, BCPSPresident, AnnaGarrett.com ReferenceHow Gut Health Affects Your Whole Body Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the relationship between gut health and systemic conditions.2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.0.05 CEU/0.5 HrUAN: 0107-0000-24-221-H01-PInitial release date: 07/15/2024Expiration date: 07/15/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram